Vanguard Portfolio Management
DAWN

Vanguard Portfolio Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Vanguard Portfolio Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,095,813
Closed -$44.9M – 3170
2026
Q1 		$44.9M Buy
+2,095,813
New +$29.5M ﹤0.01% 1687

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Portfolio Management's DAWN Position: Q2 2026 in Review

Vanguard Portfolio Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 2,095,813 shares — an estimated $44.9M sold.

Vanguard Portfolio Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $44.9M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Vanguard Portfolio Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Vanguard Portfolio Management sold 2,095,813 Day One Biopharmaceuticals shares in Q2 2026, an estimated $44.9M.
  • Vanguard Portfolio Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Vanguard Portfolio Management's Day One Biopharmaceuticals position peaked at $44.9M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.